Abstract
Small fresh water fishes such as the zebrafish (Danio rerio) have become important model organisms for biomedical research. They currently represent the best vertebrate embryo models in which it is possible to derive quantitative data on gene expression, signalling events and cell behavior in real time in the living animal.
Relevant phenotypes in fish mutants are similar to those of other vertebrate models and human diseases. They can be analysed in great details and much faster than in mammals. In recent years, approximately 2,500 genetically distinct fish lines have been generated by European research groups alone. Their potential, including their possible use by industry, is far from being exploited.
To promote zebrafish research in Europe, EuFishBioMed was founded and won support by the EU COST programme (http://www.cost.esf.org/). The main objective of EuFishBioMed is to establish a platform of knowledge exchange for research on small fish models with a strong focus on widening its biomedical applications and an integration of European research efforts and resources.
EuFishBioMed currently lists more than 300 member laboratories in Europe, offers funding for short-term laboratpry visits, organizes and co-sponsors meetings and workshops and has successfully lobbied for the establishment of a European Zebrafish Resource Centre. To maintain this network in the future, beyond the funding period of the COST Action, we are currently establishing the European Society for Fish Models in Biology and Medicine. 24 . Thus, zebrafish are not only excellent models for deciphering the pathophysiology of human diseases but serve also as effective tools to discover new human disease genes (for example 25 ).
In addition, small fish models are ideal for generating and experimentally validating large data-sets in vivo, making them particularly suited to the genome-wide approaches favored by systems biology 26 . By capitalizing on their transparency, the small size of the embryos, the ease of introducing markers and the possibility of achieving optical resolution at cellular and sub-cellular level, these small fishes provide vertebrate models that allow analysis of development and organ formation at a systems level in living organisms 27, 28 . Such processes can be studied against the disturbances introduced by genetic mutations and chemicals eventually allowing the integration of data into a virtual model of a vertebrate embryo.
The zebrafish is attracting increasing attention from the pharmaceutical industry as it is highly amenable to whole animal drug screeningstudies [30] [31] [32] . First examples have already appeared in the literature where drug candidates were successfully identified by screening for suppression of complex genetic defects (phenotypic rescue) in zebrafish embryos 33 . In Germany, the zebrafish embryo toxicity assay has become a DIN standard for testing the water quality of sewage plants 34 . Moreover, molecular studies suggest that the zebrafish embryo may offer a suitable alternative model for systematic testing of chemicals under the European REACH initiative 35 .
The rising interest in this field is encouraging an increasing number of researchers within the biomedical community to consider using small fish. However, the highly fragmented research endeavor and a limited awareness of the specific research topics pursued by each European laboratory, leaves a lot to be improved with respect to concerted scientific approaches and strategies. Moreover, the full potential of zebrafish has only started to be recognized in the industrial and regulatory sector.
To overcome this, we have established the European Network on Fish Biomedical Models (EuFishBioMed) and successfully applied for sponsoring by the EU COST programme (http://www.cost.eu/domains_actions).
EuFishBioMed, the European network of zebrafish researchers
The necessity for a European network of zebrafish researcher was recognized in discussions held at a break-out session of the 5th European Zebrafish Meeting in Interested parties from outside of Europe are welcome too: in particular colleagues from Australia and New Zealand eagerly subscribed to the information network, with both countries being partners in the COST programme. In addition, we count members from India, Chile, Singapore, USA and Japan.
Lobby work to promote Europe-wide standardized protocols for fish husbandry as well as regulatory guidelines concerning experimental work with these fish models ( 31 and http://eufishbiomed.kit.edu) is an on-going activity of
EuFishBioMed. This is particularly important in view of the differences in national and regional regulatory guidelines in Europe. For example even within Germany, different regulatory opinions exist as to when a zebrafish is regarded as an animal and when experimentation should thus be subject to approval by the authorities.
EuFishBioMed has gained an important role as competent advisor and authority in these matters across Europe 31 .
EuFishBioMed has been organising workshops and meetings (Table 1) 
Establishment of a European Zebrafish Resource Center
An additional important aim of EuFishBioMed is to lobby for national and 
